Berlin, December 7, 2022-Current recommendations on the supply bottleneck of nanoparticle albumin-bound paclitaxel (nab-paclitaxel)

被引：0
作者：
不详
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 02期
关键词：
PANCREATIC-CANCER; CHEMOTHERAPY; GEMCITABINE; FOLFIRINOX; SURVIVAL;
D O I：
10.1055/a-1998-7964
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [21] A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
    Yasuhiro Kato
    Yusuke Okuma
    Kageaki Watanabe
    Makiko Yomota
    Shoko Kawai
    Yukio Hosomi
    Tatsuru Okamura
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 351 - 358
  • [22] A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancer
    Kato, Yasuhiro
    Okuma, Yusuke
    Watanabe, Kageaki
    Yomota, Makiko
    Kawai, Shoko
    Hosomi, Yukio
    Okamura, Tatsuru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (02) : 351 - 358
  • [23] Angiosarcoma of the thoracic wall responded well to nanoparticle albumin-bound paclitaxel: A case report
    Hara, Naofumi
    Fujimoto, Nobukazu
    Miyamoto, Yosuke
    Yamagishi, Tomoko
    Asano, Michiko
    Fuchimoto, Yasuko
    Wada, Sae
    Ozaki, Shinji
    Nishi, Hideyuki
    Kishimoto, Takumi
    DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (02) : 114 - 116
  • [24] Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma
    Zhou, Qian
    Ching, Arthur K-K.
    Leung, Wilson K-C.
    Szeto, Carol Y-Y.
    Ho, Shuk-Mei
    Chan, Paul K-S.
    Yuan, Yun-Fei
    Lai, Paul B-S.
    Yeo, Winnie
    Wong, Nathalie
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (03) : 721 - 731
  • [25] Efficacy and safety of nanoparticle albumin-bound paclitaxel for treating metastatic breast cancer: a meta-analysis
    Zhu, Jia
    Yan, Li-Ping
    Wu, Jie
    Wang, Feng-Feng
    Mo, Chang-Gan
    Liu, Jian-Lun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (09): : 12951 - 12959
  • [26] Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
    Palumbo, Raffaella
    Sottotetti, Federico
    Trifiro, Giuseppe
    Piazza, Elena
    Ferzi, Antonella
    Gambaro, Anna
    Spinapolice, Elena Giulia
    Pozzi, Emma
    Tagliaferri, Barbara
    Teragni, Cristina
    Bernardo, Antonio
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2189 - 2199
  • [27] Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer A retrospective analysis
    Naito, Yujiro
    Tamiya, Akihiro
    Tamiya, Motohiro
    Kimura, Yohei
    Hamaguchi, Masanari
    Saijo, Nobuhiko
    Kanazu, Masaki
    Tokura, Sayoko
    Shiroyama, Takayuki
    Morisita, Naoko
    Omachi, Naoki
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Hirashima, Tomonori
    Atagi, Shinji
    MEDICINE, 2017, 96 (35)
  • [28] Safety of nanoparticle albumin-bound paclitaxel administered to breast cancer patients with clinical contraindications to paclitaxel or docetaxel: Four case reports
    Kimura, Kosei
    Tanaka, Satoru
    Iwamoto, Mitsuhiko
    Fujioka, Hiroya
    Takahashi, Yuko
    Sato, Nayuko
    Terasawa, Risa
    Tominaga, Tomo
    Ikari, Ayana
    Uchiyama, Kazuhisa
    ONCOLOGY LETTERS, 2013, 6 (04) : 881 - 884
  • [29] Nanoparticle albumin-bound paclitaxel in elder patients with advanced squamous non-small-cell lung cancer: A retrospective study
    Liu, Yang
    Dong, Yinping
    Zhu, Hui
    Jing, Wang
    Guo, Hongbo
    Yu, Jinming
    CANCER MEDICINE, 2020, 9 (04): : 1365 - 1373
  • [30] Interstitial lung disease associated with nanoparticle albumin-bound paclitaxel treatment in patients with lung cancer
    Kashiwada, Takeru
    Saito, Yoshinobu
    Terasaki, Yasuhiro
    Hisakane, Kakeru
    Takeuchi, Susumu
    Sugano, Teppei
    Miyanaga, Akihiko
    Noro, Rintaro
    Minegishi, Yuji
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (02) : 165 - 173
12345